Molybdenum cofactor deficiency associated with Dandy-Walker complex

Brain and Development

Volumn 23, Issue 8, 2001, Pages 815-818

  Arslanoglu, Sertac ^a,b   Yalaz, Mehmet ^a   Gökşen, Damla ^a   Çoker, Mahmut ^a   Tütüncüoǧlu, Sarenur ^a   Aksu, Mete ^a   Darcan, Şükran ^a   Kultursay, Nilgun ^a   Çiriş, Metin ^a   Demirtaş, Eren ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Dandy Walker complex; Dandy Walker malformation; Molybdenum cofactor deficiency; Neonatal seizures

Indexed keywords

CLONAZEPAM; MOLYBDENUM COMPLEX; PHENOBARBITAL; PTERIN DERIVATIVE; SULFATE; SULFITE; URIC ACID;

ARTICLE; BRAIN NECROSIS; CASE REPORT; CLINICAL FEATURE; CONGENITAL MALFORMATION; CRANIOFACIAL SYNOSTOSIS; DANDY WALKER SYNDROME; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; GLIOSIS; HISTORY; HUMAN; HUMAN TISSUE; INBORN ERROR OF METABOLISM; INTRACTABLE EPILEPSY; MALE; MOLYBDENUM COFACTOR DEFICIENCY; NERVE CELL LESION; NEUROPATHOLOGY; NEWBORN; NEWBORN PERIOD; SIBLING; WHITE MATTER;

BRAIN; BRAIN DISEASES, METABOLIC, INBORN; COENZYMES; DANDY-WALKER SYNDROME; HUMANS; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; METALLOPROTEINS; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; PTERIDINES; SULFUR COMPOUNDS; URIC ACID; XANTHINE DEHYDROGENASE; XANTHINES;

EID: 0035201120     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(01)00316-3     Document Type: Article

References (15)

1. Molybdenum cofactor deficiency
2. Short-term response to dietary therapy in molybdenum cofactor deficiency
3. Molybdenum cofactor deficiency-phenotypic variability in a family with a late-onset variant
4. Inherited disorders of amino acid and organic acid metabolism
5. Molybdenum cofactor deficiency: First prenatal genetic analysis
6. Prenatal diagnosis and carrier detection for molybdenum cofactor deficiency type A in northern Israel using polymorphic DNA markers
7. Molybdenum-cofactor deficiency: CT and MR findings
8. Dipsticks and convulsions
9. Blood uric acid as a pointer to the diagnosis of molybdenum cofactor deficiency
10. Diagnosis of molybdenum cofactor deficiency
11. Diagnosis of molybdenum cofactor deficiency
12. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin dependent diabetes mellitus
13. Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases
14. CT and MR appearance of the brain in two children with molybdenum cofactor deficiency
15. Molybdenum cofactor deficiency associated with Dandy-Walker malformation